The Rivkin Center Has Joined OCRA
The Rivkin Center Has Joined OCRA
This historic collaboration unites two respected organizations committed to advancing research for better treatments and a cure for ovarian cancer.

Expanding Research Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research has combined with OCRA.
Please explore the resources below to learn more about the support and tools available from OCRA.
Support The Rivkin Pilot Grant
The Rivkin Pilot Grant paves the way for innovative breakthroughs in all areas of ovarian cancer research. OCRA is proud to continue the Rivkin Center’s extraordinary legacy of hope, determination, and relentless pursuit of a cure.
Support & Resources
Research
Advocacy
Get Involved
OCRA Rivkin Family SummeRun
On July 13, 2025, join thousands of participants of all ages and fitness levels at Seattle’s Seward Park to raise awareness and fund critical research for ovarian cancer. Funds raised will support The Rivkin Pilot Grant. Registration opens in early April.
About
Related Topics

Global Research Push Resonates Across Airwaves
News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The … Continued

New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research … Continued

OCRA’s Health Equity Research Grant Recipients
In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, … Continued